NCCN pediatric osteosarcoma practice guidelines

ONCOLOGY

Volumn 10, Issue 12, 1996, Pages 1799-1812

  O'Reilly, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; COTRIMOXAZOLE; DOXORUBICIN; FOLINATE CALCIUM; GRANISETRON; IFOSFAMIDE; MESNA; METHOTREXATE; ONDANSETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

CHILD; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; OSTEOBLASTOMA; PRACTICE GUIDELINE; REVIEW;

AMPUTATION; ARM; BONE NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; LEG; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OSTEOSARCOMA;

EID: 0030463691     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Mankin HJ, Lange TA, Spanier SS: The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg [Am] 64:1121-1127, 1982.
2. White VA, Fanning CV, Ayala AG, et al: Osteosarcoma and the role of fine-needle aspiration: A study of 51 cases. Cancer 62:1238-1246, 1988.
3. Look AT, Douglass EC, Meyer WH: Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity. N Engl J Med 318:1567-1572, 1988.
4. Baldini N, Scotlandi K, Barbanti-Brodano G, et al: Expression of p-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med 333:1380-1385, 1995.
5. McKenna R, Schwinn C, Soong K, et al: Sarcomata of the osteogenic series (osteosarcoma, fibrosarcoma, chondrosarcoma, parosteal osteogenic sarcoma and sarcomata arising in abnormal bone): An analysis of 552 cases. J Bone Joint Surg [Am] 48:1-26, 1966.
6. Thorpe W, Reilly J, Rosenberg S: Prognostic significance of alkaline phosphatase measurements in patients with osteogenic sarcoma receiving chemotherapy. Cancer 43:2178-2181, 1979.
7. Link MP, Goorin AM, Horowitz M, et al: Adjuvant chemotherapy of high grade osteosarcoma of the extremity: Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop 270:8-14, 1991.
8. Meyers PA, Heller G, Healey J, et al: Chemotherapy for non-metastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol 10:5-15, 1992.
9. Aisen AM, Martel W, Braunstein EM, et al: MRI and CT evaluation of primary bone and soft-tissue tumors. Am J Roentgenol 146:749-756, 1986
10. Gillespy T, Manfrini M, Ruggieri P, et al: Staging of intraosseous extent of osteosarcoma: Correlation of preoperative CT and MR imaging with pathologic macroslides. Radiology 167:765-767, 1988.
11. Sundaram M, McGuire MH, Herbold DR, et al: Magnetic resonance imaging in planning limb-salvage surgery for primary malignant tumors of bone. J Bone Joint Surg [Am] 68:809-819, 1986.
12. Sundaram M, McGuire MH, Herbold DR: Magnetic resonance imaging of osteosarcoma. Skeletal Radiol 16:23-29, 1987.
13. Murphy WA Jr: Imaging bone tumors in the 1990s. Cancer 67:1169-1176, 1991.
14. McKillop J, Etcubanas E, Goris M: The indications for and limitations of bone scintigraphy in osteogenic sarcoma: A review of 55 patients. Cancer 48:1133-1138, 1981.
15. Enneking W, Kagan A: "Skip" metastases in osteosarcoma. Cancer 36:2192-2205, 1975.
16. Neifeld J, Michaelis L, Doppman J: Suspected pulmonary metastases: Correlation of chest x-ray, whole lung tomograms and operative findings. Cancer 39:383-387, 1977.
17. Kesselring F, Penn W: Radiological aspects of "classic" primary osteosarcoma: Value of some radiological investigations. Diagn Imaging 51:78-92, 1982.
18. Muhm J, Brown L, Crowe I, et al: Comparison of whole lung tomography and computed tomography for detecting pulmonary nodules. Am J Roentgenol 31:981-984, 1978.
19. Schaner EG, Chang AE, Doppman JL, et al: Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: A prospective radiologic-pathologic study. Am J Roentgenol 131:51-54, 1978.
20. Vanel D, Henry-Amar M, Lumbroso J, et al: Pulmonary evaluation of patients with osteosarcoma: Roles of standard radiography, tomography, CT, scintigraphy, and tomoscintigraphy. Am J Roentgenol 143:519-523, 1984.
21. Kirchner PT, Simon MA: Current concepts review. Radioisotope evaluation of skeletal disease. J Bone Joint Surg [Am] 63.673-681, 1981.
22. Link MP, Goorin AM, Miser AW, et al: The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314:1600-1606, 1986.
23. Eilber F, Giuliano A, Eckardt J, et al: Adjuvant chemotherapy for osteosarcoma: A randomized prospective trial. J Clin Oncol 5:21-26, 1987
24. Miser J, Arndt C, Smithson W, et al: Treatment of high-grade osteosarcoma (OGS) with ifosfamide (IFOS), mesna (MES), adriamycin (ADR), high-dose methotrexate (HDMTX), with or without cisplatin (CDDP). Proc Am Soc Clin Oncol 11:366, 1992
25. Provisor AJ, Ettinger LJ, Nachman JB, et al: Treatment of non-metastalic osteosarcoma of the extremity with pre- and postoperative chemotherapy, CCG-782: A report from the Children's Cancer Group. J Clin Oncol 1996 (in press).
26. Glasser DB, Lane JM, Huvos AG, et al: Survival, prognosis, and therapeutic response in osteogenic sarcoma: The Memorial Hospital experience. Cancer 69:698-708, 1992.
27. Carrasco CH, Charnsangavej C, Raymond AK, et al: Osteosarcoma: Angiographic assessment of response to preoperative chemotherapy. Radiology 170:839-842, 1989.
28. Jaffe N, Knapp J, Chuang VP, et al: Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diamminedichloroplatinum II (CDP): Angiographic, pathologic and pharmacologic studies. Cancer 51:402-407, 1983.
29. Hudson M, Jaffe MR, Jaffe N, et al: Pediatric osteosarscoma: Therapeutic strategies, results and prognostic factors derived from a 10-year experience. J Clin Oncol 8:1988-1997, 1990.
30. Lane JM, Kroll MA, Rossbach PG: New advances and concepts in amputee management after treatment for bone and soft-tissue sarcomas. Clin Orthop 256:22-28, 1990.
31. Mankin H, Doppelt S, Sullivan R, et al: Osteoarticular and intercalary allograft transplantation in the management of malignant tumors of bone. Cancer 50:613-630, 1982.
32. Gebhardt MC, Flugstad DT, Springfield DS, et al: The use of bone allografts for limb salvage in high-grade extremity osteosarcoma. Clin Orthop 270:181-196, 1991.
33. Eckardt JJ, Eilber FR, Dorey FJ, et al: The UCLA experience in limb salvage surgery for malignant tumors. Orthopedics 8:612-621, 1985.
34. Eckardt JJ, Eilber FR, Rosen G, et al: Endoprosthetic replacement for stage IIB osteosarcoma. Clin Orthop 270:202-213, 1991.
35. Capanna R, Morris HG, Campanacci D, et al: Modular uncemeted prosthetic reconstruction after resection of tumours of the distal femur. J Bone Joint Surg [Br] 76-B: 178-186, 1994.
36. Chao EYS, Sim FH: Modular prosthetic system for segmental bone and joint replacement after tumor resection. Orthopedics 8:641-651, 1985.
37. Gebhart MJ, Lane JM, McCormack Jr, et al: Limb salvage in bone sarcomas - Memorial Hospital experience. Orthopedics 8:626-635, 1985.
38. Simon MA, Aschliman MA, Thomas N, et al: Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg [Am] 68:1331-1337, 1986.
39. Roufgraff BT, Simon MA, Kneisl JS, et al: Limb salvage compared with amputation for osteosarcoma of the distal end of the femur: A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg 76A:649-656, 1994
40. Ramanna L, Waxman A, Binney G, et al: Thallium-201 scintigraphy in bone sarcoma: Comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 31:561-572, 1990.
41. Menendez LR, Fideler BM, Mirra J Thallium-201 scanning for the evaluation of osteosarcoma and soft tissue sarcoma. J Bone Joint Surg 75-A:526-531, 1993.
42. Huvos A, Rosen G, Marcove RC: Primary osteogenic sarcoma. Pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection and prosthetic bone replacement. Arch Pathol Lab Med 101:14-18, 1977.
43. Rosen G, Marcove RC, Caparros B, et al: Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163-2177, 1979.
44. Rosen G, Marcove RC, Huvos AG, et al: Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol 106(suppl):55-67, 1983
45. Winkler K, Beron G, Kotz R, et al: Neoadjuvant chemotherapy for osteogenic sarcoma: Results of a Cooperative German/Austrian Study. J Clin Oncol 2:617-624, 1984.
46. Mirro J Jr, Rao BN, Kumar M, et al. A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J Pediatr Surg 25:120-124, 1990.
47. American Society of Clinical Oncology. American society of clinical oncology recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. J Clin Oncol 12:2471-2508, 1994.
48. Pizzo PA: Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328:1323-1332, 1993.
49. Hughes WT, Rivera GK, Schell MJ, et al: Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 316:1627-1632, 1987.
50. Telander R, Pairolero P, Pritchard D, et al: Resection of pulmonary metastatic osteogenic sarcoma in children. Surgery 84:335-341, 1978.
51. Putnam JB, Roth J, Wesley M, et al: Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: Analysis of prognostic factors. Ann Thorac Surg 36:516-523, 1983.
52. Rosen G, Huvos A, Mosende C, et al: Chemotherapy and thoracotomy for metastatic osteogenic sarcoma. Cancer 41:841-849, 1978.
53. Meyer WH, Schell MJ, Kumar APM, et al: Thoracotomy for pulmonary metastatic osteosarcoma: An analysis of prognostic indicators of survival. Cancer 59:374-379, 1987.
54. Goorin AM, Shuster JJ, Baker A, et al: Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: Results from the Multi-Institutional Osteosarcoma Study. J Clin Oncol 9:600-605, 1991.
55. Marina NM, Pratt CB, Rao BN, et al: Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer 70:2722-2727, 1992.
56. Meyers PA, Heller G, Healey JH, et al: Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 11:449-453, 1993.
57. Harris M, Gieser P, Link M, et al: Treatment of metastatic osteosarcoma at diagnosis: A Pediatric Oncology Group study. Proc Am Soc Clin Oncol 14:445, 1995.